Morgan Stanley
KYTH

Morgan Stanley’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Morgan Stanley’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-426,951
Closed -$32M – 7073
2015
Q3 		$32M Buy
426,951
+273,342
+178% +$20.4M 0.01% 1057
2015
Q2 		$11.6M Buy
153,609
+8,683
+6% +$465K ﹤0.01% 1967
2015
Q1 		$7.27M Buy
144,926
+114,983
+384% +$4.83M ﹤0.01% 2395
2014
Q4 		$1.04M Buy
29,943
+21,388
+250% +$746K ﹤0.01% 4122
2014
Q3 		$280K Buy
8,555
+3,006
+54% +$106K ﹤0.01% 4951
2014
Q2 		$214K Sell
5,549
-10,601
-66% -$370K ﹤0.01% 5117
2014
Q1 		$643K Buy
16,150
+8,824
+120% +$395K ﹤0.01% 4379
2013
Q4 		$274K Buy
7,326
+2,694
+58% +$112K ﹤0.01% 4864
2013
Q3 		$211K Buy
+4,632
New +$139K ﹤0.01% 4857

Morgan Stanley's KYTH Position: Q4 2015 in Review

Morgan Stanley sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 426,951 shares — an estimated $32M sold.

Morgan Stanley first reported a position in KYTH in Q3 2013 and held it in 9 quarters. The position peaked at $32M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Morgan Stanley reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Morgan Stanley sold 426,951 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $32M.
  • Morgan Stanley first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 9 quarters.
  • Morgan Stanley's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $32M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Morgan Stanley's 13F filing for Q4 2015, filed 9 Feb 2016.